Kissei Pharmaceutical Co., Ltd. (4547.T)

JPY 3515.0

(0.14%)

Long Term Debt Summary of Kissei Pharmaceutical Co., Ltd.

  • Kissei Pharmaceutical Co., Ltd.'s latest annual long term debt in 2023 was - JPY , down 0.0% from previous year.
  • Kissei Pharmaceutical Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was - JPY , down 0.0% from previous quarter.
  • Kissei Pharmaceutical Co., Ltd. reported annual long term debt of - JPY in 2022, down 0.0% from previous year.
  • Kissei Pharmaceutical Co., Ltd. reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • Kissei Pharmaceutical Co., Ltd. reported quarterly long term debt of - JPY for 2024 Q1, down 0.0% from previous quarter.
  • Kissei Pharmaceutical Co., Ltd. reported quarterly long term debt of - JPY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Kissei Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual Long Term Debt of Kissei Pharmaceutical Co., Ltd. (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 - JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY -100.0%
2019 13 Million JPY -99.33%
2018 1.93 Billion JPY 2.88%
2017 1.87 Billion JPY 13.29%
2016 1.65 Billion JPY 11.29%
2015 1.48 Billion JPY 1.71%
2014 1.46 Billion JPY 3.83%
2013 1.4 Billion JPY -7.61%
2012 1.52 Billion JPY -1.42%
2011 1.54 Billion JPY -12.5%
2010 1.76 Billion JPY 36.63%
2009 1.29 Billion JPY 53.86%
2008 841 Million JPY 108.68%
2007 403 Million JPY -96.72%
2006 12.27 Billion JPY -0.21%
2005 12.29 Billion JPY -43.88%
2004 21.91 Billion JPY 0.0%

Peer Long Term Debt Comparison of Kissei Pharmaceutical Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 100.0%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 100.0%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 100.0%
Shionogi & Co., Ltd. 8.75 Billion JPY 100.0%
Wakamoto Pharmaceutical Co.,Ltd. - JPY NaN%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 100.0%
Kaken Pharmaceutical Co., Ltd. - JPY NaN%
Eisai Co., Ltd. 134.77 Billion JPY 100.0%
Morishita Jintan Co., Ltd. 106 Million JPY 100.0%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY 100.0%
Mochida Pharmaceutical Co., Ltd. - JPY NaN%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 100.0%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 100.0%
Tsumura & Co. 54.37 Billion JPY 100.0%
Torii Pharmaceutical Co., Ltd. 22 Million JPY 100.0%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 100.0%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 100.0%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 100.0%
KYORIN Holdings, Inc. 435 Million JPY 100.0%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 100.0%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 100.0%
SymBio Pharmaceuticals Limited - JPY NaN%
MedRx Co., Ltd - JPY NaN%
Mizuho Medy Co.,Ltd. - JPY NaN%
Solasia Pharma K.K. 27 Million JPY 100.0%
Modalis Therapeutics Corporation 412.5 Million JPY 100.0%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 100.0%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 100.0%
Cyfuse Biomedical K.K. 345 Million JPY 100.0%
Toho Holdings Co., Ltd. 28.16 Billion JPY 100.0%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 100.0%